Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial.
Grünig E, Benjamin N, Lange TJ, Krueger U, Klose H, Neurohr C, Wilkens H, Halank M, Seyfarth HJ, Held M, Traube A, Pernow M, Grover ER, Egenlauf B, Gerhardt F, Viethen T, Rosenkranz S. Grünig E, et al. Among authors: halank m. Respiration. 2016;92(6):362-370. doi: 10.1159/000450759. Epub 2016 Oct 27. Respiration. 2016. PMID: 27784026 Free article. Clinical Trial.
Bosentan therapy for portopulmonary hypertension.
Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804. Eur Respir J. 2005. PMID: 15738295 Free article.
[A role for combination therapy in pulmonary arterial hypertension].
Behr J, Borst MM, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G. Behr J, et al. Among authors: halank m. Pneumologie. 2005 Oct;59(10):730-5. doi: 10.1055/s-2005-915556. Pneumologie. 2005. PMID: 16222588 German.
Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.
Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Mereles D, et al. Among authors: halank m. Circulation. 2006 Oct 3;114(14):1482-9. doi: 10.1161/CIRCULATIONAHA.106.618397. Epub 2006 Sep 18. Circulation. 2006. PMID: 16982941 Clinical Trial.
Impairment of respiratory muscle function in pulmonary hypertension.
Kabitz HJ, Schwoerer A, Bremer HC, Sonntag F, Walterspacher S, Walker D, Schaefer V, Ehlken N, Staehler G, Halank M, Klose H, Ghofrani HA, Hoeper MM, Gruenig E, Windisch W. Kabitz HJ, et al. Among authors: halank m. Clin Sci (Lond). 2008 Jan;114(2):165-71. doi: 10.1042/CS20070238. Clin Sci (Lond). 2008. PMID: 17764445
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension.
Hoeper MM, Gall H, Seyfarth HJ, Halank M, Ghofrani HA, Winkler J, Golpon H, Olsson KM, Nickel N, Opitz C, Ewert R. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2009 Jul;34(1):132-7. doi: 10.1183/09031936.00130408. Epub 2009 Feb 27. Eur Respir J. 2009. PMID: 19251782 Free article. Clinical Trial.
Standard PAH therapy improves long term survival in CTEPH patients.
Seyfarth HJ, Halank M, Wilkens H, Schäfers HJ, Ewert R, Riedel M, Schuster E, Pankau H, Hammerschmidt S, Wirtz H. Seyfarth HJ, et al. Among authors: halank m. Clin Res Cardiol. 2010 Sep;99(9):553-6. doi: 10.1007/s00392-010-0156-4. Epub 2010 Apr 25. Clin Res Cardiol. 2010. PMID: 20419456
171 results